Avanos Medical, Inc. (AVNS) has a consensus analyst rating of Hold, based on 8 analysts covering the stock. Of those, 1 recommend buying, 6 recommend holding, and 1 recommend selling.
The analyst consensus price target for AVNS is $23.00, representing a -6.6% downside from the current price of $24.63. Price targets range from a low of $20.00 to a high of $26.00.
